Articles From: Valeant Pharmaceuticals Sends Letter To Physician Customers to Valley Financial Corporation Reports Record Net Income and Record Diluted Earnings per Share for Third Quarter 2014; Declares Quarterly Cash Dividend


2014/11/7
Valeant Pharmaceuticals Sends Letter To Physician Customers Canada NewsWire LAVAL, Quebec , Nov.
Sign-up for Valeant Pharmaceuticals Sends Letter To Physician Customers investment picks
LAVAL, Quebec , Oct.
Sign-up for Valeant Pharmaceuticals To Announce 2014 Third Quarter Results On October 20, 2014 investment picks
LAVAL, Quebec , Sept.
Sign-up for Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA investment picks
Overall Same Store Organic Growth (unadjusted for generics) Expected to Exceed 15% in Third Quarter Bausch + Lomb Expected to Continue to Deliver Greater Than 10% Organic Growth (unadjusted) Valeant 3Q Results Expected to Beat Consensus on Revenue and Be Better than Guidance on Cash EPS, Organic Growth, Restructuring Charges and Adjusted Cash Flow from Operations Expect Continued Strong Double-digit Same Store Organic Growth in the Fourth Quarter Will Announce Third Quarter Results on October 20 LAVAL, Quebec , Sept.
Sign-up for Valeant Provides Update On Third Quarter Results And Sends Letter To Allergan CEO And Lead Independent Director investment picks
By Russ Britt, MarketWatch After monthslong struggle, Valeant will drop Allergan buyout plan LOS ANGELES (MarketWatch) -- It seems Allergan Inc. doesn't have to worry about Valeant Pharmaceuticals International Inc. anymore.
Sign-up for Valeant says it won't meet Actavis's offer investment picks
2014/11/20
By Angela Chen Valeant Pharmaceuticals Inc. is launching a new $2 billion securities repurchase program, just days after losing to its bid to buy Botox maker Allergan Inc. to Actavis PLC.
Sign-up for Valeant Sets $2 Billion Buyback Plan After Losing Allergan investment picks
Valeant Pharmaceuticals International Inc. (VRX) and partner Pershing Square Capital Management plan to boost their bid for Allergan Inc. (AGN) by $15 a share, The Wall Street Journal reported late Tuesday, citing unnamed sources.
Sign-up for Valeant to boost Allergan bid by $15 a share: report investment picks
Allergan Inc. shares (AGN) rose more than 3% in premarket trade Monday, after Valeant Pharmaceuticals International Inc. (VRX) said it was prepared to improve its offer for Allergan to a value of at least $200 a share.
Sign-up for Valeant willing to improve Allergan offer to value of at least $200 a share investment picks
Valeant Pharmaceuticals' stock (VRX) got a midday lift Thursday, after the drugmaker announced a new $2 billion securities repurchase program.
Sign-up for Valeant's stock rises after new $2 billion buyback plan announced investment picks
Valence Health , a leading provider of clinical integration, population health and value-based care solutions, announced today that it has entered into a collaboration agreement with Humana Inc. (NYSE: HUM) to help provider organizations transition into Medicare Advantage (MA) value-based arrangements.
Sign-up for Valence Health and Humana Announce Value-Based Care Collaboration for Medicare Members investment picks
Valener declares its quarterly dividends Canada NewsWire MONTREAL , Nov.
Sign-up for Valener declares its quarterly dividends investment picks
Valener's recurring net income increases for a third consecutive year Canada NewsWire MONTREAL , Nov.
Sign-up for Valener's recurring net income increases for a third consecutive year investment picks
2014/10/23
SAN ANTONIO , Oct.
Sign-up for Valero Energy Corporation Declares Regular Cash Dividend on Common Stock investment picks
2014/10/14
SAN ANTONIO , Oct.
Sign-up for Valero Energy Partners LP Increases Quarterly Cash Distribution investment picks
2014/11/12
SAN ANTONIO , Nov.
Sign-up for Valero Energy Partners LP Reports Third Quarter 2014 Results investment picks
2014/11/4
SAN ANTONIO , Nov.
Sign-up for Valero Energy Reports Third Quarter 2014 Results investment picks
Valeura announces new discoveries in Turkey and provides third quarter 2014 operational update Canada NewsWire CALGARY , Oct.
Sign-up for Valeura announces new discoveries in Turkey and provides third quarter 2014 operational update investment picks
Valeura announces new strategy for its 100% Banarli licence in Turkey and third quarter 2014 financial and operating results Canada NewsWire CALGARY , Nov.
Sign-up for Valeura announces new strategy for its 100% Banarli licence in Turkey and third quarter 2014 financial and operating results investment picks
Valeura announces strong November natural gas prices of $10.62 per Mcf, Tie-in of new discoveries and projected 16% increase in quarter over quarter sales Canada NewsWire CALGARY , Dec.
Sign-up for Valeura announces strong November natural gas prices of $10.62 per Mcf, Tie-in of new discoveries and projected 16% increase in quarter over quarter sales investment picks
2014/10/29
Validus Holdings, Ltd.
Sign-up for Validus Announces Third Quarter and Nine Month 2014 Financial Results investment picks
2014/10/2
Validus Holdings, Ltd.
Sign-up for Validus Holdings Completes Acquisition of Western World investment picks
2014/11/5
Validus Holdings, Ltd.
Sign-up for Validus Holdings, Ltd. Announces Quarterly Dividend investment picks
2014/9/18
Validus Holdings, Ltd.
Sign-up for Validus Holdings, Ltd. To Participate in the JMP Securities Financial Services & Real Estate Conference on September 30, 2014 investment picks
2014/12/4
Validus Holdings, Ltd.
Sign-up for Validus Holdings, Ltd. to Release Fourth Quarter 2014 Financial Results on January 29, 2015 investment picks
ADTRAN ® , Inc. , (NASDAQ:ADTN), today announced Valley Business Solutions (VBS) is leveraging ADTRAN’s ProCloud Wi-Fi managed service program to expand its portfolio beyond hardware-based solutions to become a managed service provider (MSP). ADTRAN’s ProCloud Wi-Fi uniquely allows resellers the option to use the program as a turnkey service offering.
Sign-up for Valley Business Solutions Reinvents its Business with ADTRAN ProCloud Wi-Fi investment picks
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Valley Financial Corp.
Sign-up for VALLEY FINANCIAL CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Valley Financial Corp. Over the Proposed Sale of the Company to BNC Bancorp - VYFC investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Valeant Pharmaceuticals Sends Letter To Physician Customers to Valley Financial Corporation Reports Record Net Income and Record Diluted Earnings per Share for Third Quarter 2014; Declares Quarterly Cash Dividend
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent